Medicare Enrolled

Dr. David Kheradyar, M.D.

Neurology · Inglewood, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
323 N PRAIRIE AVE, Inglewood, CA 90301
3106800560
In practice since 2006 (19 years)
NPI: 1518917640 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kheradyar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kheradyar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kheradyar

Dr. David Kheradyar is a neurology specialist in Inglewood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kheradyar performed 2,384 Medicare services across 1,106 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kheradyar received a total of $111,967 from 59 pharmaceutical and/or device companies across 773 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kheradyar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 20% volume in CA $111,967 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,384
Medicare services
Top 20% in CA for neurology
1,106
Unique beneficiaries
$121
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~125 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,163 $108 $175
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
372 $88 $150
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
332 $66 $150
EEG, extended monitoring
A test that records electrical activity in the brain while the patient is both awake and asleep.
135 $412 $600
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
123 $76 $125
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
119 $138 $375
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
72 $219 $1,900
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
42 $109 $375
Nerve conduction study, 9-10 studies
A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function.
26 $188 $1,600
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$111,967
Total received (2018-2024)
Avg $15,995/year across 7 years
Top 6% in CA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
773
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$101,936 (91.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,031 (9.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$6,651
2023
$11,931
2022
$14,976
2021
$14,353
2020
$16,031
2019
$26,416
2018
$21,608

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$3,159
Novartis Pharmaceuticals Corporation
$434
UCB, Inc.
$404
TG Therapeutics, Inc.
$332
PFIZER INC.
$207
MDD US Operations, LLC
$203
Lundbeck LLC
$198
Celgene Corporation
$190
Otsuka America Pharmaceutical, Inc.
$185
ABBVIE INC.
$182
SK Life Science, Inc.
$151
Lilly USA, LLC
$114
ARGENX US, INC.
$105
Amneal Pharmaceuticals LLC
$91
Vanda Pharmaceuticals Inc.
$70
EMD Serono, Inc.
$68
Mallinckrodt Hospital Products Inc.
$67
ANI Pharmaceuticals, Inc.
$60
CATALYST PHARMACEUTICALS, INC.
$54
Neurelis, Inc.
$49
Eisai Inc.
$48
Boston Scientific Corporation
$45
Neurocrine Biosciences, Inc.
$35
HARMONY BIOSCIENCES LLC
$31
LivaNova USA, Inc.
$28
GENZYME CORPORATION
$28
Aucta Pharmaceuticals, Inc.
$27
Kyowa Kirin, Inc.
$22
MITSUBISHI TANABE PHARMA AMERICA, INC.
$21
JAZZ PHARMACEUTICALS INC.
$20
Alnylam Pharmaceuticals Inc.
$16
Harmony Biosciences Llc
$8
Top 3 companies account for 60.1% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$101,161
Novartis Pharmaceuticals Corporation
$1,346
GENZYME CORPORATION
$1,105
UCB, Inc.
$893
EMD Serono, Inc.
$522
ABBVIE INC.
$494
PFIZER INC.
$491
SK Life Science, Inc.
$392
TG Therapeutics, Inc.
$332
Greenwich Biosciences, Inc.
$287
Otsuka America Pharmaceutical, Inc.
$285
Celgene Corporation
$279
ACADIA Pharmaceuticals Inc
$261
ARGENX US, INC.
$257
Teva Pharmaceuticals USA, Inc.
$250
Lilly USA, LLC
$246
MDD US Operations, LLC
$240
Lundbeck LLC
$224
AbbVie Inc.
$213
Amneal Pharmaceuticals LLC
$197
Eisai Inc.
$171
Amgen Inc.
$154
Allergan, Inc.
$139
Avanir Pharmaceuticals, Inc.
$129
Biohaven Pharmaceutical Holding Company Ltd.
$118
Alnylam Pharmaceuticals Inc.
$112
Abbott Laboratories
$111
Neurocrine Biosciences, Inc.
$107
Neurelis, Inc.
$97
LivaNova USA, Inc.
$93
Alexion Pharmaceuticals, Inc.
$86
MITSUBISHI TANABE PHARMA AMERICA, INC.
$85
Supernus Pharmaceuticals, Inc.
$82
Horizon Therapeutics plc
$77
CATALYST PHARMACEUTICALS, INC.
$74
Vanda Pharmaceuticals Inc.
$70
Mallinckrodt Hospital Products Inc.
$67
ANI Pharmaceuticals, Inc.
$60
Bayer HealthCare Pharmaceuticals Inc.
$56
Strongbridge US INC.
$55
Catalyst Pharmaceuticals, Inc.
$49
Acorda Therapeutics, Inc
$48
EISAI INC.
$46
Boston Scientific Corporation
$45
Sumitomo Pharma America, Inc.
$37
Impax Laboratories, Inc.
$37
US WorldMeds, LLC
$33
HARMONY BIOSCIENCES LLC
$31
Allergan Inc.
$30
Aucta Pharmaceuticals, Inc.
$27
Banner Life Sciences, LLC
$24
Kyowa Kirin, Inc.
$22
Mylan Pharmaceuticals Inc.
$20
Janssen Pharmaceuticals, Inc
$20
JAZZ PHARMACEUTICALS INC.
$20
SANOFI-AVENTIS U.S. LLC
$19
Vertiflex, Inc.
$18
Sunovion Pharmaceuticals Inc.
$15
Harmony Biosciences Llc
$8
Top 3 companies account for 92.5% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AJOVY · AMVUTTRA · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · BAFIERTAM · BRIUMVI · Betaseron · Briviact · COMIRNATY · CONFIRM RX · COPAXONE · CREXONT · EMGALITY · EPIDIOLEX · Epidiolex · FIRDAPSE · FYCOMPA · Fycompa · GILENYA · GOCOVRI · Glatiramer Acetate · Gocovri · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · LEMTRADA · LEQEMBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · Motpoly XR · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · ONPATTRO · OXTELLAR XR · Ongentys · PAXLOVID · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Rebif · SOLIRIS · SPINRAZA · Superion ISS · TECFIDERA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VNS Therapy SenTiva Model 1000 Generator · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · XCOPRI · Xadago · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for neurology in CA.

Looking for a neurology specialist in Inglewood?
Compare neurologists in the Inglewood area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
555
Per 100K population
5.6
County median income
$87,760
Nearest hospital
CENTINELA HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kheradyar is a clinical cardiology specialist, with above-average Medicare volume (top 20% in CA), with speaking/promotional industry engagement in the top 6% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kheradyar experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kheradyar performed 1,163 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kheradyar receive payments from pharmaceutical companies?
Yes. Dr. Kheradyar received a total of $111,967 from 59 companies across 773 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kheradyar's costs compare to other neurologists in Inglewood?
Dr. Kheradyar's average Medicare payment per service is $121. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kheradyar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →